Seres Therapeutics (MCRB) Beats Q4 Earnings Estimates by $0.16
Seres Therapeutics (NASDAQ:MCRB) reported quarterly earnings results on March 12, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Read more
